Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reveal® XT Performance Trial

NCT00680927 is registered in ClinicalTrials.gov with Medtronic BRC as lead sponsor.

NCT NCT00680927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00680927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reveal® XT Performance Trial
Lead sponsor
Medtronic BRC
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2007
Completion date
August 31, 2008
Enrollment
247 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, risk of cardiac arrhythmias